Obesity and appetite control

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Suzuki, Keisuke ^a   Jayasena, Channa N ^a   Bloom, Stephen R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AGOUTI RELATED PROTEIN; ANOREXIGENIC AGENT; ANTIOBESITY AGENT; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; EXENDIN 4; EXENDIN[9-39]; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCAGON LIKE PEPTIDE 2; LIRAGLUTIDE; NEUROPEPTIDE Y; OBESTATIN; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY; PEPTIDE YY [3-36]; PROGLUCAGON; PROTEIN C FOS; RECOMBINANT GHRELIN; RECOMBINANT HORMONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; HORMONE;

ACUTE PANCREATITIS; ANOREXIA; ANOREXIA NERVOSA; APOPTOSIS; APPETITE; BLOOD SAMPLING; BRAIN; BRAIN STEM; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; ESTERIFICATION; FOOD INTAKE; GASTROINTESTINAL TRACT; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERLIPIDEMIA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMUNOREACTIVITY; IN VITRO STUDY; INSULIN RESISTANCE; INTESTINE; LIVER; MEDIATOR; NERVE CELL NETWORK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS; PANCREATIC POLYPEPTIDE SECRETING CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STOMACH ACID SECRETION; STOMACH EMPTYING; STOMACH MOTILITY; TREATMENT OUTCOME; VAGUS NERVE; VASODILATATION; BARIATRIC SURGERY; BIOLOGICAL MODEL; METABOLISM; METHODOLOGY; MICROBIOLOGY; NERVE CELL; PATHOLOGY; PHYSIOLOGY; REWARD; RISK FACTOR;

APPETITE; APPETITE REGULATION; BARIATRIC SURGERY; GASTROINTESTINAL HORMONES; HORMONES; HUMANS; HYPOTHALAMUS; INTESTINES; MODELS, BIOLOGICAL; NEURONS; OBESITY; REWARD; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84864996745     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/824305     Document Type: Review

References (252)

1. Field A. E., Coakley E. H., Must A., Spadano J. L., Laird N., Dietz W. H., Rimm E., Colditz G. A., Impact of overweight on the risk of developing common chronic diseases during a 10-year period Archives of Internal Medicine 2001 161 13 1581 1586 (Pubitemid 32681139)
2. Must A., Spadano J., Coakley E. H., Field A. E., Colditz G., Dietz W. H., The disease burden associated with overweight and obesity The Journal of the American Medical Association 1999 282 16 1523 1529 (Pubitemid 29504045)
3. Li F., Fisher K. J., Harmer P., Prevalence of overweight and obesity in older U.S. adults: estimates from the 2003 Behavioral Risk Factor Surveillance System survey Journal of the American Geriatrics Society 2005 53 4 737 739 (Pubitemid 41623509)
4. Mokdad A. H., Ford E. S., Bowman B. A., Dietz W. H., Vinicor F., Bales V. S., Marks J. S., Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 The Journal of the American Medical Association 2003 289 1 76 79 (Pubitemid 36026281)
5. Hagan S., Niswender K. D., Neuroendocrine regulation of food intake Pediatric Blood Cancer 2012 58 1 149 153
6. Chaudhri O. B., Wynne K., Bloom S. R., Can gut hormones control appetite and prevent obesity? Diabetes Care 2008 31 supplement 2 S284 289
7. Michel M. C., Beck-Sickinger A., Cox H., Doods H. N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T., XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors Pharmacological Reviews 1998 50 1 143 150 (Pubitemid 28158845)
8. Tatemoto K., Mutt V., Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides Nature 1980 285 5764 417 418 (Pubitemid 10047227)
9. Lin S., Boey D., Herzog H., NPY and Y receptors: lessons from transgenic and knockout models Neuropeptides 2004 38 4 189 200 (Pubitemid 39161911)
10. Ekblad E., Sundler F., Distribution of pancreatic polypeptide and peptide YY Peptides 2002 23 2 251 261 (Pubitemid 34127963)
11. Eberlein G. A., Eysselein V. E., Schaeffer M., Layer P., Grandt D., Goebell H., Niebel W., Davis M., Lee T. D., Shively J. E., Reeve J. R., A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36) Peptides 1989 10 4 797 803 (Pubitemid 19228495)
12. Adrian T. E., Ferri G. L., Bacarese-Hamilton A. J., Fuessl H. S., Polak J. M., Bloom S. R., Human distribution and release of a putative new gut hormone, peptide YY Gastroenterology 1985 89 5 1070 1077 (Pubitemid 16231572)
13. Adrian T. E., Savage A. P., Bacarese-Hamilton A. J., Wolfe K., Besterman H. S., Bloom S. R., Peptide YY abnormalities in gastrointestinal diseases Gastroenterology 1986 90 2 379 384 (Pubitemid 16136680)
14. Wahab P. J., Hopman W. P., Jansen J. B., Basal and fat-stimulated plasma peptide YY levels in celiac disease Digestive Diseases and Sciences 2001 46 11 2504 2509 (Pubitemid 33042358)
15. Le Roux C. W., Ghatei M. A., Gibbs J. S., Bloom S. R., The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension Heart 2005 91 2 241 242
16. Batterham R. L., Cowley M. A., Small C. J., Herzog H., Cohen M. A., Dakin C. L., Wren A. M., Brynes A. E., Low M. J., Ghatei M. A., Cone R. D., Bloom S. R., Gut hormone PYY3-36 physiologically inhibits food intake Nature 2002 418 6898 650 654
17. Batterham R. L., Cohen M. A., Ellis S. M., Le Roux C. W., Withers D. J., Frost G. S., Ghatei M. A., Bloom S. R., Inhibition of food intake in obese subjects by peptide YY3-36 The New England Journal of Medicine 2003 349 10 941 948 (Pubitemid 37064767)
18. Tschp M., Castaneda T. R., Joost H. G., Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature 2004 430 6996 1 165
19. Spiller R. C., Trotman I. F., Higgins B. E., The ileal brakeinhibition of jejunal motility after ileal fat perfusion in man Gut 1984 25 4 365 374 (Pubitemid 14136456)
20. Wen J., Phillips S. F., Sarr M. G., Kost L. J., Holst J. J., PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon The American Journal of Physiology 1995 269 6, part 1 G945 G952
21. Ashby D., Bloom S. R., Recent progress in PYY researchan update report for 8th NPY meeting Peptides 2007 28 2 198 202 (Pubitemid 46178463)
22. Sloth B., Holst J. J., Flint A., Gregersen N. T., Astrup A., Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects The American Journal of Physiology 2007 292 4 E1062 E1068
23. Bartolomé M. A., Borque M., Martinez-Sarmiento J., Aparicio E., Hernndez C., Cabrerizo L., Fernndez-Represa J. A., Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty Obesity Surgery 2002 12 3 324 327 (Pubitemid 34621023)
24. Misra M., Miller K. K., Tsai P., Gallagher K., Lin A., Lee N., Herzog D. B., Klibanski A., Elevated peptide YY levels in adolescent girls with anorexia nervosa The Journal of Clinical Endocrinology and Metabolism 2006 91 3 1027 1033 (Pubitemid 43357776)
25. Kim B. J., Carlson O. D., Jang H. J., Elahi D., Berry C., Egan J. M., Peptide YY is secreted after oral glucose administration in a gender-specific manner The Journal of Clinical Endocrinology and Metabolism 2005 90 12 6665 6671 (Pubitemid 41759330)
26. Pfluger P. T., Kampe J., Castaneda T. R., Vahl T., D'Alessio D. A., Kruthaupt T., Benoit S. C., Cuntz U., Rochlitz H. J., Moehlig M., Pfeiffer A. F. H., Koebnick C., Weickert M. O., Otto B., Spranger J., Tschp M. H., Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36 The Journal of Clinical Endocrinology and Metabolism 2007 92 2 583 588
27. Halatchev I. G., Cone R. D., Peripheral administration of PYY3-36 produces conditioned taste aversion in mice Cell Metabolism 2005 1 3 159 168 (Pubitemid 43960603)
28. Abbott C. R., Monteiro M., Small C. J., Sajedi A., Smith K. L., Parkinson J. R. C., Ghatei M. A., Bloom S. R., The inhibitory effects of peripheral administration of peptide YY 3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway Brain Research 2005 1044 1 127 131 (Pubitemid 40616060)
29. Koda S., Date Y., Murakami N., Shimbara T., Hanada T., Toshinai K., Niijima A., Furuya M., Inomata N., Osuye K., Nakazato M., The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats Endocrinology 2005 146 5 2369 2375 (Pubitemid 40577525)
30. Morley J. E., Levine A. S., Grace M., Kneip J., Peptide YY (PYY), a potent orexigenic agent Brain Research 1985 341 1 200 203 (Pubitemid 15246340)
31. Stanley B. G., Daniel D. R., Chin A. S., Leibowitz S. F., Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion Peptides 1985 6 6 1205 1211 (Pubitemid 16166878)
32. Kanatani A., Mashiko S., Murai N., Sugimoto N., Ito J., Fukuroda T., Fukami T., Morin N., Macneil D. J., Van Der Ploeg L. H. T., Saga Y., Nishimura S., Ihara M., Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice Endocrinology 2000 141 3 1011 1016 (Pubitemid 32260445)
33. Batterham R. L., Ffytche D. H., Rosenthal J. M., Zelaya F. O., Barker G. J., Withers D. J., Williams S. C. R., PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans Nature 2007 450 7166 106 109 (Pubitemid 350070563)
34. Talsania T., Anini Y., Siu S., Drucker D. J., Brubaker P. L., Peripheral exendin-4 and peptide YY3-36 synergistically reduce food intake through different mechanisms in mice Endocrinology 2005 146 9 3748 3756 (Pubitemid 41175742)
35. De Silva A., Salem V., Long C. J., The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans Cell Metabolism 2011 14 5 700 706
36. Gradin K. A., Buus C. L., Li J. Y., Frbert O., Simonsen U., Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats British Journal of Pharmacology 2006 148 5 703 713 (Pubitemid 43993061)
37. Nordheim U., Hofbauer K. G., Stimulation of NPY Y2 receptors by PYY3-36 reveals divergent cardiovascular effects of endogenous NPY in rats on different dietary regimens The American Journal of Physiology 2004 286 1 R138 R142
38. Asakawa A., Inui A., Yuzuriha H., Ueno N., Katsuura G., Fujimiya M., Fujino M. A., Niijima A., Meguid M. M., Kasuga M., Characterization of the effects of pancreatic polypeptide in the regulation of energy balance Gastroenterology 2003 124 5 1325 1336 (Pubitemid 36531807)
39. Parker R. M., Herzog H., Regional distribution of Y-receptor subtype mRNAs in rat brain European Journal of Neuroscience 1999 11 4 1431 1448 (Pubitemid 29142202)
40. Whitcomb D. C., Taylor I. L., Vigna S. R., Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain The American Journal of Physiology 1990 259 4, part 1 G687 G691
41. Clark J. T., Kalra P. S., Crowley W. R., Kalra S. P., Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats Endocrinology 1984 115 1 427 429 (Pubitemid 14086844)
42. Kojima S., Ueno N., Asakawa A., Sagiyama K., Naruo T., Mizuno S., Inui A., A role for pancreatic polypeptide in feeding and body weight regulation Peptides 2007 28 2 459 463 (Pubitemid 46176251)
43. Adrian T. E., Bloom S. R., Bryant M. G., Polak J. M., Heitz P. H., Barnes A. J., Distribution and release of human pancreatic polypeptide Gut 1976 17 12 940 944 (Pubitemid 8027537)
44. Uhe A. M., Szmukler G. I., Collier G. R., Hansky J., O'Dea K., Young G. P., Potential regulators of feeding behavior in anorexia nervosa The American Journal of Clinical Nutrition 1992 55 1 28 32
45. Jorde R., Burhol P. G., Fasting and postprandial plasma pancreatic polypeptide (PP) levels in obesity International Journal of Obesity 1984 8 5 393 397 (Pubitemid 15215946)
46. Wisen O., Bjorvell H., Cantor P., Johansson C., Theodorsson E., Plasma concentrations of regulatory peptides in obesity following modified sham feeding (MSF) and a liquid test meal Regulatory Peptides 1992 39 1 43 54
47. Glaser B., Zoghlin G., Pienta K., Vinik A. I., Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance Hormone and Metabolic Research 1988 20 5 288 292
48. Lassmann V., Vague P., Vialettes B., Simon M. C., Low plasma levels of pancreatic polypeptide in obesity Diabetes 1980 29 6 428 430 (Pubitemid 11018461)
49. Zipf W. B., O'Dorisio T. M., Cataland S., Dixon K., Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome The Journal of Clinical Endocrinology and Metabolism 1983 57 5 1074 1080 (Pubitemid 14204314)
50. Ueno N., Inui A., Iwamoto M., Kaga T., Asakawa A., Okita M., Fujimiya M., Nakajima Y., Ohmoto Y., Ohnaka M., Nakaya Y., Miyazaki J. I., Kasuga M., Decreased food intake and body weight in pancreatic polypeptide- overexpressing mice Gastroenterology 1999 117 6 1427 1432
51. Batterham R. L., Le Roux C. W., Cohen M. A., Park A. J., Ellis S. M., Patterson M., Frost G. S., Ghatei M. A., Bloom S. R., Pancreatic polypeptide reduces appetite and food intake in humans The Journal of Clinical Endocrinology and Metabolism 2003 88 8 3989 3992 (Pubitemid 37034556)
52. Berntson G. G., Zipf W. B., O'Dorisio T. M., Hoffman J. A., Chance R. E., Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome Peptides 1993 14 3 497 503
53. Holst J. J., On the physiology of GIP and GLP-1 Hormone and Metabolic Research 2004 36 11-12 747 754 (Pubitemid 40115894)
54. Tang-Christensen M., Vrang N., Larsen P. J., Glucagon-like peptide containing pathways in the regulation of feeding behaviour International Journal of Obesity 2001 25 supplement 5 S42 S47
55. Tucker J. D., Dhanvantari S., Brubaker P. L., Proglucagon processing in islet and intestinal cell lines Regulatory Peptides 1996 62 1 29 35 (Pubitemid 26146196)
56. Orskov C., Rabenhoj L., Wettergren A., Kofod H., Holst J. J., Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans Diabetes 1994 43 4 535 539 (Pubitemid 24096293)
57. Larsen P. J., Tang-Christensen M., Holst J. J., rskov C., Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem Neuroscience 1997 77 1 257 270 (Pubitemid 27060323)
58. Shughrue P. J., Lane M. V., Merchenthaler I., Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus Endocrinology 1996 137 11 5159 5162 (Pubitemid 26403362)
59. Larsen P. J., Tang-Christensen M., Jessop D. S., Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat Endocrinology 1997 138 10 4445 4455 (Pubitemid 27408493)
60. Rinaman L., Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus The American Journal of Physiology 1999 277 2, part 2 R582 R590
61. Nowak A., Bojanowska E., Effects of peripheral or central GLP-1 receptor blockade on leptin-induced suppression of appetite Journal of Physiology and Pharmacology 2008 59 3 501 510
62. Burcelin R., Da Costa A., Drucker D., Thorens B., Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor Diabetes 2001 50 8 1720 1728 (Pubitemid 33641588)
63. Dardevet D., Moore M. C., DiCostanzo C. A., Farmer B., Neal D. W., Snead W., Lautz M., Cherrington A. D., Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors The American Journal of Physiology 2005 289 5 G806 G814
64. Holst J. J., The physiology of glucagon-like peptide 1 Physiological Reviews 2007 87 4 1409 1439 (Pubitemid 350041474)
65. Yamato E., Ikegami H., Takekawa K., Fujisawa T., Nakagawa Y., Hamada Y., Ueda H., Ogihara T., Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1) Hormone and Metabolic Research 1997 29 2 56 59 (Pubitemid 27170091)
66. Harkavyi A., Whitton P. S., Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection British Journal of Pharmacology 2010 159 3 495 501
67. Nakagawa A., Satake H., Nakabayashi H., Nishizawa M., Furuya K., Nakano S., Kigoshi T., Nakayama K., Uchida K., Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells Autonomic Neuroscience: Basic Clinical 2004 110 1 36 43 (Pubitemid 38180536)
68. Vahl T. P., Drazen D. L., Seeley R. J., D'Alessio D. A., Woods S. C., Meal-anticipatory glucagon-like peptide-1 secretion in rats Endocrinology 2010 151 2 569 575
69. Cummings D. E., Overduin J., Gastrointestinal regulation of food intake The Journal of Clinical Investigation 2007 117 1 13 23 (Pubitemid 46048445)
70. Verdich C., Flint A., Gutzwiller J. P., Nslund E., Beglinger C., Hellstrm P. M., Long S. J., Morgan L. M., Holst J. J., Astrup A., A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on Ad Libitum energy intake in humans The Journal of Clinical Endocrinology and Metabolism 2001 86 9 4382 4389 (Pubitemid 32848563)
71. Vilsbll T., Agers H., Krarup T., Holst J. J., Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects The Journal of Clinical Endocrinology and Metabolism 2003 88 1 220 224 (Pubitemid 36115169)
72. Deacon C. F., Circulation and degradation of GIP and GLP-1 Hormone and Metabolic Research 2004 36 11-12 761 765 (Pubitemid 40115896)
73. Mentlein R., Gallwitz B., Schmidt W. E., Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum European Journal of Biochemistry 1993 214 3 829 835 (Pubitemid 23188160)
74. Zander M., Madsbad S., Madsen J. L., Holst J. J., Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and -cell function in type 2 diabetes: a parallel-group study The Lancet 2002 359 9309 824 830 (Pubitemid 34233752)
75. Eng J., Kleinman W. A., Singh L., Singh G., Raufman J. P., Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas The Journal of Biological Chemistry 1992 267 11 7402 7405
76. DeFronzo R. A., Ratner R. E., Han J., Kim D. D., Fineman M. S., Baron A. D., Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 Diabetes Care 2005 28 5 1092 1100 (Pubitemid 40616618)
77. Egan J. M., Bulotta A., Hui H., Perfetti R., GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells Diabetes/Metabolism Research and Reviews 2003 19 2 115 123 (Pubitemid 36417195)
78. Harkavyi A., Whitton P. S., Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection British Journal of Pharmacology 2010 159 3 495 501
79. Bunck M. C., Corner A., Eliasson B., Effects of exenatide on measures of beta-cell function after 3 years in metformin-treated patients with type 2 diabetes Diabetes Care 2011 34 9 2041 2047
80. Cegla J., Tan T. M., Bloom S. R., Gut-brain cross-talk in appetite regulation Current Opinion in Clinical Nutrition and Metabolic Care 2010 13 5 588 593
81. Gale E. A., GLP-1-based therapies and the exocrine pancreas: more light, or just more heat? Diabetes 2012 61 5 986 988
82. Bataille D., Gespach C., Tatemoto K., Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities Peptides 1981 2 supplement 2 41 44 (Pubitemid 12118280)
83. Ghatei M. A., Uttenthal L. O., Christofides N. D., Bryant M. G., Bloom S. R., Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract The Journal of Clinical Endocrinology and Metabolism 1983 57 3 488 495 (Pubitemid 13005511)
84. Schjoldager B. T., Baldissera F. G., Mortensen P. E., Holst J. J., Christiansen J., Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man European Journal of Clinical Investigation 1988 18 5 499 503
85. Schjoldager B., Mortensen P. E., Myhre J., Christiansen J., Holst J. J., Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions Digestive Diseases and Sciences 1989 34 9 1411 1419 (Pubitemid 19247399)
86. Cohen M. A., Ellis S. M., Le Roux C. W., Batterham R. L., Park A., Patterson M., Frost G. S., Ghatei M. A., Bloom S. R., Oxyntomodulin suppresses appetite and reduces food intake in humans The Journal of Clinical Endocrinology and Metabolism 2003 88 10 4696 4701 (Pubitemid 37357514)
87. Dakin C. L., Gunn I., Small C. J., Edwards C. M. B., Hay D. L., Smith D. M., Ghatei M. A., Bloom S. R., Oxyntomodulin inhibits food intake in the rat Endocrinology 2001 142 10 4244 4250 (Pubitemid 32907050)
88. Wynne K., Park A. J., Small C. J., Meeran K., Ghatei M. A., Frost G. S., Bloom S. R., Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial International Journal of Obesity 2006 30 12 1729 1736 (Pubitemid 44863404)
89. Dakin C. L., Small C. J., Batterham R. L., Neary N. M., Cohen M. A., Patterson M., Ghatei M. A., Bloom S. R., Peripheral oxyntomodulin reduces food intake and body weight gain in rats Endocrinology 2004 145 6 2687 2695 (Pubitemid 38686215)
90. Baggio L. L., Huang Q., Brown T. J., Drucker D. J., Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure Gastroenterology 2004 127 2 546 558 (Pubitemid 39091903)
91. Fehmann H. C., Jiang J., Schweinfurth J., Wheeler M. B., Boyd A. E. 3rd, Goke B., Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin- 4, and exendin(9-39) Peptides 1994 15 3 453 456 (Pubitemid 24223320)
92. Sowden G. L., Drucker D. J., Weinshenker D., Swoap S. J., Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor The American Journal of Physiology 2007 292 2 R962 R970
93. Ban K., Kim K. H., Cho C. K., Sauvé M., Diamandis E. P., Backx P. H., Drucker D. J., Husain M., Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor Endocrinology 2010 151 4 1520 1531
94. Druce M. R., Minnion J. S., Field B. C., Patel S. R., Shillito J. C., Tilby M., Beale K. E. L., Murphy K. G., Ghatei M. A., Bloom S. R., Investigation of structure-activity relationships of oxyntomodulin (Oxm) using oxm analogs Endocrinology 2009 150 4 1712 1722
95. Heppner K. M., Habegger K. M., Day J., Pfluger P. T., Perez-Tilve D., Ward B., Gelfanov V., Woods S. C., DiMarchi R., Tschp M., Glucagon regulation of energy metabolism Physiology Behavior 2010 100 5 545 548
96. Jones B. J., Tan T., Bloom S. R., Minireview: glucagon in stress and energy homeostasis Endocrinology 2012 153 3 1049 1054
97. Geary N., Kissileff H. R., Pi-Sunyer F. X., Hinton V., Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men The American Journal of Physiology 1992 262 6, part 2 R975 R980
98. Martin J. R., Novin D., Decreased feeding in rats following hepatic portal infusion of glucagon Physiology Behavior 1977 19 4 461 466 (Pubitemid 8317175)
99. Schulman J. L., Carleton J. L., Whitney G., Whitehorn J. C., Effect of glucagon on food intake and body weight in man Journal of Applied Physiology 1957 11 3 419 421
100. Pocai A., Carrington P. E., Adams J. R., Wright M., Eiermann G., Zhu L., Du X., Petrov A., Lassman M. E., Jiang G., Liu F., Miller C., Tota L. M., Zhou G., Zhang X., Sountis M. M., Santoprete A., Capito' E., Chicchi G. G., Thornberry N., Bianchi E., Pessi A., Marsh D. J., SinhaRoy R., Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice Diabetes 2009 58 10 2258 2266
101. Day J. W., Ottaway N., Patterson J. T., Gelfanov V., Smiley D., Gidda J., Findeisen H., Bruemmer D., Drucker D. J., Chaudhary N., Holland J., Hembree J., Abplanalp W., Grant E., Ruehl J., Wilson H., Kirchner H., Lockie S. H., Hofmann S., Woods S. C., Nogueiras R., Pfluger P. T., Perez-Tilve D., Dimarchi R., Tschp M. H., A new glucagon and GLP-1 co-agonist eliminates obesity in rodents Nature Chemical Biology 2009 5 10 749 757
102. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K., Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 1999 402 6762 656 660 (Pubitemid 129516334)
103. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M. S., Suganuma T., Matsukura S., Kangawa K., Nakazato M., Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans Endocrinology 2000 141 11 4255 4261
104. Hosoda H., Kojima M., Kangawa K., Biological, physiological, and pharmacological aspects of ghrelin Journal of Pharmacological Sciences 2006 100 5 398 410 (Pubitemid 44609531)
105. Cowley M. A., Smith R. G., Diano S., Tschp M., Pronchuk N., Grove K. L., Strasburger C. J., Bidlingmaier M., Esterman M., Heiman M. L., Garcia-Segura L. M., Nillni E. A., Mendez P., Low M. J., Sotonyi P., Friedman J. M., Liu H., Pinto S., Colmers W. F., Cone R. D., Horvath T. L., The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis Neuron 2003 37 4 649 661 (Pubitemid 36262986)
106. Tschop M., Smiley D. L., Heiman M. L., Ghrelin induces adiposity in rodents Nature 2000 407 6806 908 913
107. Murakami N., Hayashida T., Kuroiwa T., Nakahara K., Ida T., Mondal M. S., Nakazato M., Kojima M., Kangawa K., Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats The Journal of Endocrinology 2002 174 2 283 288 (Pubitemid 34965767)
108. Cummings D. E., Purnell J. Q., Frayo R. S., Schmidova K., Wisse B. E., Weigle D. S., A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans Diabetes 2001 50 8 1714 1719 (Pubitemid 33641587)
109. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S., A role for ghrelin in the central regulation of feeding Nature 2001 409 6817 194 198 (Pubitemid 32144284)
110. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R. L., Heiman M. L., Lehnert P., Fichter M., Tschp M., Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa European Journal of Endocrinology 2001 145 5 669 673
111. Cummings D. E., Weigle D. S., Frayo R. S., Breen P. A., Ma M. K., Patchen Dellinger E., Purnell J. Q., Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery The New England Journal of Medicine 2002 346 21 1623 1630 (Pubitemid 34755670)
112. le Roux C. W., Patterson M., Vincent R. P., Hunt C., Ghatei M. A., Bloom S. R., Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects The Journal of Clinical Endocrinology and Metabolism 2005 90 2 1068 1071 (Pubitemid 40279235)
113. Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., Hosoda H., Shimizu W., Yamagishi M., Oya H., Koh H., Yutani C., Kangawa K., Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors Circulation 2001 104 17 2034 2038 (Pubitemid 33027043)
114. Cummings D. E., Clement K., Purnell J. Q., Vaisse C., Foster K. E., Frayo R. S., Schwartz M. W., Basdevant A., Weigle D. S., Elevated plasma ghrelin levels in Prader-Willi syndrome Nature Medicine 2002 8 7 643 644 (Pubitemid 34778697)
115. Wang L., Saint-Pierre D. H., Taché Y., Peripheral ghrelin selectively increases Fos expression in neuropeptide Ysynthesizing neurons in mouse hypothalamic arcuate nucleus Neuroscience Letters 2002 325 1 47 51 (Pubitemid 34521976)
116. Chen H. Y., Trumbauer M. E., Chen A. S., Weingarth D. T., Adams J. R., Frazier E. G., Shen Z., Marsh D. J., Feighner S. D., Guan X. M., Ye Z., Nargund R. P., Smith R. G., Van Der Ploeg L. H. T., Howard A. D., Macneil D. J., Qian S., Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein Endocrinology 2004 145 6 2607 2612 (Pubitemid 38686204)
117. Lawrence C. B., Snape A. C., Baudoin F. M., Luckman S. M., Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers Endocrinology 2002 143 1 155 162 (Pubitemid 34056414)
118. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., Kangawa K., Nakazato M., The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats Gastroenterology 2002 123 4 1120 1128
119. Malik S., McGlone F., Bedrossian D., Dagher A., Ghrelin modulates brain activity in areas that control appetitive behavior Cell Metabolism 2008 7 5 400 409 (Pubitemid 351598026)
120. Zhao C. M., Furnes M. W., Stenstrm B., Kulseng B., Chen D., Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study Cell and Tissue Research 2008 331 3 575 587
121. Lacquaniti A., Donato V., Chirico V., Buemi A., Buemi M., Obestatin: an interesting but controversial gut hormone Annals of Nutrition Metabolism 2011 59 24 193 199
122. Gourcerol G., Coskun T., Craft L. S., Mayer J. P., Heiman M. L., Wang L., Million M., St.-Pierre D.H. D. H., Taché Y., Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents Obesity 2007 15 11 2643 2652
123. Gibbs J., Young R. C., Smith G. P., Cholecystokinin decreases food intake in rats Journal of Comparative and Physiological Psychology 1973 84 3 488 495
124. Liddle R. A., Goldfine I. D., Rosen M. S., Taplitz R. A., Williams J. A., Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction The Journal of Clinical Investigation 1985 75 4 1144 1152 (Pubitemid 15087139)
125. Kissileff H. R., Pi-Sunyer F. X., Thornton J., Smith G. P., C-terminal octapeptide of cholecystokinin decreases food intake in man The American Journal of Clinical Nutrition 1981 34 2 154 160 (Pubitemid 11186304)
126. West D. B., Fey D., Woods S. C., Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats The American Journal of Physiology 1984 246 5, part 2 R776 R787
127. Crawley J. N., Beinfeld M. C., Rapid development of tolerance to the behavioural actions of cholecystokinin Nature 1983 302 5910 703 706 (Pubitemid 13120271)
128. Moran T. H., Baldessarini A. R., Salorio C. F., Lowery T., Schwartz G. J., Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin The American Journal of Physiology 1997 272 4, part 2 R1245 R1251
129. Moran T. H., Katz L. F., Plata-Salaman C. R., Schwartz G. J., Disordered food intake and obesity in rats lacking cholecystokinin A receptors The American Journal of Physiology 1998 274 3, part 2 R618 R625
130. Wank S. A., Cholecystokinin receptors The American Journal of Physiology 1995 269 5, part 1 G628 G646
131. Owyang C., Heldsinger A., Vagal control of satiety and hormonal regulation of appetite Journal of Neurogastroenterology and Motility 2011 17 4 338 348
132. Barrachina M. D., Martnez V., Wang L., Wei J. Y., Taché Y., Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice Proceedings of the National Academy of Sciences of the United States of America 1997 94 19 10455 10460 (Pubitemid 27407063)
133. Reda T. K., Geliebter A., Pi-Sunyer F. X., Amylin, food intake, and obesity Obesity Research 2002 10 10 1087 1091 (Pubitemid 135688927)
134. Reinehr T., de Sousa G., Niklowitz P., Roth C. L., Amylin and its relation to insulin and lipids in obese children before and after weight loss Obesity 2007 15 8 2006 2011 (Pubitemid 47402232)
135. Rushing P. A., Hagan M. M., Seeley R. J., Lutz T. A., Woods S. C., Amylin: a novel action in the brain to reduce body weight Endocrinology 2000 141 2 850 853 (Pubitemid 32250511)
136. Thompson R. G., Pearson L., Schoenfeld S. L., Kolterman O. G., Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin Diabetes Care 1998 21 6 987 993 (Pubitemid 28488793)
137. Weyer C., Maggs D. G., Young A. A., Kolterman O. G., Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control Current Pharmaceutical Design 2001 7 14 1353 1373 (Pubitemid 32798815)
138. Polonsky K. S., Given B. D., Van Cauter E., Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects The Journal of Clinical Investigation 1988 81 2 442 448 (Pubitemid 18075238)
139. Air E. L., Benoit S. C., Blake Smith K. A., Clegg D. J., Woods S. C., Acute third ventricular administration of insulin decreases food intake in two paradigms Pharmacology Biochemistry and Behavior 2002 72 1-2 423 429 (Pubitemid 34251354)
140. Porte D. Jr., Woods S. C., Regulation of food intake and body weight by insulin Diabetologia 1981 20, supplement 3 274 280 (Pubitemid 11159659)
141. Menendez J. A., Atrens D. M., Insulin and the paraventricular hypothalamus: modulation of energy balance Brain Research 1991 555 2 193 201
142. Baura G. D., Foster D. M., Porte D. Jr., Kahn S. E., Bergman R. N., Cobelli C., Schwartz M. W., Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain The Journal of Clinical Investigation 1993 92 4 1824 1830 (Pubitemid 23304549)
143. Corp E. S., Woods S. C., Porte D. Jr., Dorsa D. M., Figlewicz D. P., Baskin D. G., Localization of 125I-insulin binding sites in the rat hypothalamus by quantitative autoradiography Neuroscience Letters 1986 70 1 17 22 (Pubitemid 16023232)
144. Schwartz M. W., Sipols A. J., Marks J. L., Sanacora G., White J. D., Scheurink A., Kahn S. E., Baskin D. G., Woods S. C., Figlewicz D. P., Porte D., Inhibition of hypothalamic neuropeptide Y gene expression by insulin Endocrinology 1992 130 6 3608 3616
145. Considine R. V., Sinha M. K., Heiman M. L., Kriauciunas A., Stephens T. W., Nyce M. R., Ohannesian J. P., Marco C. C., Mckee L. J., Bauer T. L., Caro J. F., Serum immunoreactive-leptin concentrations in normal-weight and obese humans The New England Journal of Medicine 1996 334 5 292 295 (Pubitemid 26033933)
146. Saad M. F., Riad-Gabriel M. G., Khan A., Sharma A., Michael R., Jinagouda S. D., Boyadjian R., Steil G. M., Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity The Journal of Clinical Endocrinology and Metabolism 1998 83 2 453 459 (Pubitemid 28496522)
147. Banks W. A., Kastin A. J., Huang W., Jaspan J. B., Maness L. M., Leptin enters the brain by a saturable system independent of insulin Peptides 1996 17 2 305 311 (Pubitemid 26124406)
148. Baskin D. G., Breininger J. F., Schwartz M. W., Leptin receptor mrna identifies a subpopulation of neuropeptide y neurons activated by fasting in rat hypothalamus Diabetes 1999 48 4 828 833 (Pubitemid 29153083)
149. Schwartz M. W., Woods S. C., Porte D. Jr., Seeley R. J., Baskin D. G., Central nervous system control of food intake Nature 2000 404 6778 661 671 (Pubitemid 30205071)
150. Sahu A., Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance Frontiers in Neuroendocrinology 2003 24 4 225 253 (Pubitemid 38064317)
151. Pelleymounter M. A., Cullen M. J., Baker M. B., Hecht R., Winters D., Boone T., Collins F., Effects of the obese gene product on body weight regulation in ob/ob mice Science 1995 269 5223 540 543
152. Blevins J. E., Baskin D. G., Hypothalamic-brainstem circuits controlling eating Forum of Nutrition 2010 63 133 140
153. Tartaglia L. A., The leptin receptor The Journal of Biological Chemistry 1997 272 10 6093 6096 (Pubitemid 27118072)
154. Fei H., Okano H. J., Li C., Lee G. H., Zhao C., Darnell R., Friedman J. M., Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues Proceedings of the National Academy of Sciences of the United States of America 1997 94 13 7001 7005 (Pubitemid 27281980)
155. Chen H., Charlat O., Tartaglia L. A., Woolf E. A., Weng X., Ellis S. J., Lakey N. D., Culpepper J., More K. J., Breitbart R. E., Duyk G. M., Tepper R. I., Morgenstern J. P., Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice Cell 1996 84 3 491 495 (Pubitemid 26060722)
156. Coleman D. L., Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice Diabetologia 1978 14 3 141 148 (Pubitemid 8286141)
157. Halaas J. L., Gajiwala K. S., Maffei M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M., Weight-reducing effects of the plasma protein encoded by the obese gene Science 1995 269 5223 543 546
158. Farooqi I. S., Matarese G., Lord G. M., Keogh J. M., Lawrence E., Agwu C., Sanna V., Jebb S. A., Perna F., Fontana S., Lechler R. I., Depaoli A. M., O'Rahilly S., Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency The Journal of Clinical Investigation 2002 110 8 1093 1103 (Pubitemid 35215890)
159. Mnzberg H., Leptin-signaling pathways and leptin resistance Forum of Nutrition 2010 63 123 132
160. Banks W. A., Anorectic effects of circulating cytokines: role of the vascular blood-brain barrier Nutrition 2001 17 5 434 437 (Pubitemid 32457804)
161. Benarroch E. E., Neural control of feeding behavior: overview and clinical correlations Neurology 2010 74 20 1643 1650
162. Simpson K. A., Martin N. M., Bloom S. R., Hypothalamic regulation of food intake and clinical therapeutic applications Arquivos Brasileiros de Endocrinologia e Metabologia 2009 53 2 120 128
163. Stanley S., Wynne K., McGowan B., Bloom S., Hormonal regulation of food intake Physiological Reviews 2005 85 4 1131 1158 (Pubitemid 41363743)
164. Suzuki K., Simpson K. A., Minnion J. S., Shillito J. C., Bloom S. R., The role of gut hormones and the hypothalamus in appetite regulation Endocrine Journal 2010 57 5 359 372
165. Mayer J., Thomas D. W., Regulation of food intake and obesity Science 1967 156 3773 328 337
166. Broadwell R. D., Brightman M. W., Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood The Journal of Comparative Neurology 1976 166 3 257 283
167. Huszar D., Lynch C. A., Fairchild-Huntress V., Dunmore J. H., Fang Q., Berkemeier L. R., Gu W., Kesterson R. A., Boston B. A., Cone R. D., Smith F. J., Campfield L. A., Burn P., Frank L., Targeted disruption of the melanocortin-4 receptor results in obesity in mice Cell 1997 88 1 131 141 (Pubitemid 27180337)
168. Chen A. S., Marsh D. J., Trumbauer M. E., Frazier E. G., Guan X. M., Yu H., Rosenblum C. I., Vongs A., Feng Y., Cao L., Metzger J. M., Strack A. M., Camacho R. E., Mellin T. N., Nunes C. N., Min W., Fisher J., Gopal-Truter S., MacIntyre D. E., Chen H. Y., Van Der Ploeg L. H. T., Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass Nature Genetics 2000 26 1 97 102
169. Abbott C. R., Rossi M., Kim M., Alahmed S. H., Taylor G. M., Ghatei M. A., Smith D. M., Bloom S. R., Investigation of the melanocyte stimulating hormones on food intakeLack of evidence to support a role for the melanocortin-3-receptor Brain Research 2000 869 1-2 203 210 (Pubitemid 30345791)
170. Kristensen P., Judge M. E., Thim L., Ribel U., Christjansen K. N., Wulff B. S., Clausen J. T., Jensen P. B., Madsen O. D., Vrang N., Larsen P. J., Hastrup S., Hypothalamic CART is a new anorectic peptide regulated by leptin Nature 1998 393 6680 72 76 (Pubitemid 28240256)
171. Abbott C. R., Rossi M., Wren A. M., Murphy K. G., Kennedy A. R., Stanley S. A., Zollner A. N., Morgan D. G. A., Morgan I., Ghatei M. A., Small C. J., Bloom S. R., Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei Endocrinology 2001 142 8 3457 3463 (Pubitemid 32681753)
172. Broberger C., Johansen J., Johansson C., Schalling M., Hkfelt T., The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice Proceedings of the National Academy of Sciences of the United States of America 1998 95 25 15043 15048 (Pubitemid 29003753)
173. Allen Y. S., Adrian T. E., Allen J. M., Neuropeptide Y distribution in the rat brain Science 1983 221 4613 877 879
174. Stanley B. G., Kyrkouli S. E., Lampert S., Leibowitz S. F., Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity Peptides 1986 7 6 1189 1192 (Pubitemid 17226746)
175. Ollmann M. M., Wilson B. D., Yang Y. K., Kerns J. A., Chen Y., Gantz I., Barsh G. S., Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein Science 1997 278 5335 135 138 (Pubitemid 27446294)
176. Leibowitz S. F., Hammer N. J., Chang K., Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat Physiology Behavior 1981 27 6 1031 1040
177. Ludwig D. S., Tritos N. A., Mastaitis J. W., Kulkarni R., Kokkotou E., Elmquist J., Lowell B., Flier J. S., Maratos-Flier E., Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance The Journal of Clinical Investigation 2001 107 3 379 386 (Pubitemid 32157970)
178. Marsh D. J., Weingarth D. T., Novi D. E., Chen H. Y., Trumbauer M. E., Chen A. S., Guan X. M., Jiang M. M., Feng Y., Camacho R. E., Shen Z., Frazier E. G., Yu H., Metzger J. M., Kuca S. J., Shearman L. P., Gopal-Truter S., MacNeil D. J., Strack A. M., MacIntyre D. E., Van Der Ploeg L. H. T., Qian S., Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism Proceedings of the National Academy of Sciences of the United States of America 2002 99 5 3240 3245 (Pubitemid 34240616)
179. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R. M., Tanaka H., Williams S. C., Richardson J. A., Kozlowski G. P., Wilson S., Arch J. R. S., Buckingham R. E., Haynes A. C., Carr S. A., Annan R. S., McNulty D. E., Liu W. S., Terrett J. A., Elshourbagy N. A., Bergsma D. J., Yanagisawa M., Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior Cell 1998 92 4 573 585 (Pubitemid 28101119)
180. Peyron C., Tighe D. K., van den Pol A. N., De Lecea L., Heller H. C., Sutcliffe J. G., Kilduff T. S., Neurons containing hypocretin (orexin) project to multiple neuronal systems The Journal of Neuroscience 1998 18 23 9996 10015 (Pubitemid 28543775)
181. Nishino S., Ripley B., Overeem S., Lammers G. J., Mignot E., Hypocretin (orexin) deficiency in human narcolepsy The Lancet 2000 355 9197 39 40 (Pubitemid 30072183)
182. Cheon H. G., Antiobesity effects of melanin-concentrating hormone receptor 1 (MCH-R1) antagonists Handbook of Experimental Pharmacology 2012 209 383 403
183. Wynne K., Stanley S., McGowan B., Bloom S., Appetite control The Journal of Endocrinology 2005 184 2 291 318 (Pubitemid 40347231)
184. Jacobowitz D. M., O'Donohue T. L., -Melanocyte stimulating hormone: immunohistochemical identification and mapping in neurons of rat brain Proceedings of the National Academy of Sciences of the United States of America 1978 75 12 6300 6304 (Pubitemid 9100995)
185. Bernardis L. L., Bellinger L. L., The dorsomedial hypothalamic nucleus revisited: 1986 update Brain Research 1987 434 3 321 381 (Pubitemid 17101572)
186. Guan X. M., Yu H., Trumbauer M., Frazier E., Van der Ploeg L. H., Chen H., Induction of neuropeptide Y expression in dorsomedial hypothalamus of diet-induced obese mice Neuroreport 1998 9 15 3415 3419 (Pubitemid 28566122)
187. Xu B., Goulding E. H., Zang K., Cepoi D., Cone R. D., Jones K. R., Tecott L. H., Reichardt L. F., Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor Nature Neuroscience 2003 6 7 736 742 (Pubitemid 36792889)
188. Unger T. J., Calderon G. A., Bradley L. C., Sena-Esteves M., Rios M., Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity The Journal of Neuroscience 2007 27 52 14265 14274
189. Gonzlez J. A., Reimann F., Burdakov D., Dissociation between sensing and metabolism of glucose in sugar sensing neurones The Journal of Physiology 2009 587 1, part 1 41 48
190. Bailey E. F., A tasty morsel: the role of the dorsal vagal complex in the regulation of food intake and swallowing. Focus on BDNF/TrkB signaling interacts with GABAergic system to inhibit rhythmic swallowing in the rat, by Bariohay et al. The American Journal of Physiology 2008 295 4 R1048 R1049
191. Zheng H., Patterson L. M., Phifer C. B., Berthoud H. R., Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections The American Journal of Physiology 2005 289 1 R247 R258
192. Geerling J. C., Shin J. W., Chimenti P. C., Loewy A. D., Paraventricular hypothalamic nucleus: axonal projections to the brainstem The Journal of Comparative Neurology 2010 518 9 1460 1499
193. Grill H. J., Kaplan J. M., The neuroanatomical axis for control of energy balance Frontiers in Neuroendocrinology 2002 23 1 2 40 (Pubitemid 34121907)
194. van der Kooy D., Area postrema: site where cholecystokinin acts to decrease food intake Brain Research 1984 295 2 345 347
195. Schwartz T. W., Holst J. J., Fahrenkrug J., Jensen S. L., Nielsen O. V., Rehfeld J. F., de Muckadell O. B., Stadil F., Vagal, cholinergic regulation of pancreatic polypeptide secretion. The Journal of Clinical Investigation 1978 61 3 781 789
196. Ellacott K. L., Halatchev I. G., Cone R. D., Characterization of leptin-responsive neurons in the caudal brainstem Endocrinology 2006 147 7 3190 3195 (Pubitemid 43901109)
197. Moriarty P., Dimaline R., Thompson D. G., Dockray G. J., Characterization of cholecystokinin(A) and cholecystokinin(B) receptors expressed by vagal afferent neurons Neuroscience 1997 79 3 905 913 (Pubitemid 27292686)
198. Burdyga G., Spiller D., Morris R., Lal S., Thompson D., Saeed S., Dimaline R., Varro A., Dockray G. J., Expression of the leptin receptor in rat and human nodose ganglion neurones Neuroscience 2002 109 2 339 347 (Pubitemid 34098973)
199. Nelson D. W., Sharp J. W., Brownfield M. S., Raybould H. E., Ney D. M., Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat Endocrinology 2007 148 5 1954 1962 (Pubitemid 46997024)
200. Burdyga G., Lal S., Spiller D., Jiang W., Thompson D., Attwood S., Saeed S., Grundy D., Varro A., Dimaline R., Dockray G. J., Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans Gastroenterology 2003 124 1 129 139 (Pubitemid 36055346)
201. Phillips R. J., Powley T. L., Gastric volume rather than nutrient content inhibits food intake The American Journal of Physiology 1996 271 3, part 2 R766 R769
202. Schwartz G. J., The role of gastrointestinal vagal afferents in the control of food intake: current prospects Nutrition 2000 16 10 866 873
203. Schwartz G. J., Salorio C. F., Skoglund C., Moran T. H., Gut vagal afferent lesions increase meal size but do not block gastric preload-induced feeding suppression The American Journal of Physiology 1999 276 6, part 2 R1623 R1629
204. Randich A., Tyler W. J., Cox J. E., Meller S. T., Kelm G. R., Bharaj S. S., Responses of celiac and cervical vagal afferents to infusions of lipids in the jejunum or ileum of the rat The American Journal of Physiology 2000 278 1 R34 R43
205. Kral J. G., Paez W., Wolfe B. M., Vagal nerve function in obesity: therapeutic implications World Journal of Surgery 2009 33 10 1995 2006
206. Krolczyk G., Zurowski D., Sobocki J., Slowiaczek M. P., Laskiewicz J., Matyja A., Zaraska K., Zaraska W., Thor P. J., Effects of continuous microchip (MC) vagal neuromodulation on gastrointestinal function in rats Journal of Physiology and Pharmacology 2001 52 4, part 1 705 715 (Pubitemid 34164756)
207. Val-Laillet D., Biraben A., Randuineau G., Malbert C. H., Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in adult obese minipigs Appetite 2010 55 2 245 252
208. Gil K., Bugajski A., Thor P., Electrical vagus nerve stimulation decreases food consumption and weight gain in rats fed a high-fat diet Journal of Physiology and Pharmacology 2011 62 6 637 646
209. Fox E. A., A genetic approach for investigating vagal sensory roles in regulation of gastrointestinal function and food intake Autonomic Neuroscience: Basic Clinical 2006 126-127 9 29 (Pubitemid 43816935)
210. Berthoud H. R., Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance Obesity 2006 14 supplement 5 197S 200S
211. Rolls E. T., Taste, olfactory and food texture reward processing in the brain and obesity International Journal of Obesity 2011 35 4 550 561
212. Whitwell J. L., Sampson E. L., Loy C. T., Warren J. E., Rossor M. N., Fox N. C., Warren J. D., VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration NeuroImage 2007 35 1 207 213 (Pubitemid 46240946)
213. Cota D., Tschp M. H., Horvath T. L., Levine A. S., Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Research Reviews 2006 51 1 85 107 (Pubitemid 43782532)
214. Zhang M., Gosnell B. A., Kelley A. E., Intake of high-fat food is selectively enhanced by Mu opioid receptor stimulation within the nucleus accumbens The Journal of Pharmacology and Experimental Therapeutics 1998 285 2 908 914 (Pubitemid 28237478)
215. Zheng H., Patterson L. M., Berthoud H. R., Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens The Journal of Neuroscience 2007 27 41 11075 11082 (Pubitemid 47574162)
216. Di Marzo V., Goparaju S. K., Wang L., Liu J., Btkai S., Jrai Z., Fezza F., Miura G. I., Palmiter R. D., Sugiura T., Kunos G., Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 2001 410 6830 822 825 (Pubitemid 32303781)
217. Haber S. N., Knutson B., The reward circuit: linking primate anatomy and human imaging Neuropsychopharmacology 2010 35 1 4 26
218. Szczypka M. S., Kwok K., Brot M. D., Marck B. T., Matsumoto A. M., Donahue B. A., Palmiter R. D., Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice Neuron 2001 30 3 819 828 (Pubitemid 32607345)
219. DelParigi A., Chen K., Salbe A. D., Reiman E. M., Tataranni P. A., Sensory experience of food and obesity: a positron emission tomography study of the brain regions affected by tasting a liquid meal after a prolonged fast NeuroImage 2005 24 2 436 443 (Pubitemid 41359039)
220. Bragulat V., Dzemidzic M., Bruno C., Cox C. A., Talavage T., Considine R. V., Kareken D. A., Food-related odor probes of brain reward circuits during hunger: a pilot FMRI study Obesity 2010 18 8 1566 1571
221. Stubbs R. J., Johnstone A. M., O'Reilly L. M., Barton K., Reid C., The effect of covertly manipulating the energy density of mixed diets on ad libitum food intake in 'pseudo free-living' humans International Journal of Obesity and Related Metabolic Disorders 1998 22 10 980 987 (Pubitemid 28451197)
222. de Lorgeril M., Salen P., Martin J. L., Monjaud I., Delaye J., Mamelle N., Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study Circulation 1999 99 6 779 785 (Pubitemid 29083018)
223. Pi-Sunyer F. X., Use of lifestyle changes treatment plans and drug therapy in controlling cardiovascular and metabolic risk factors Obesity 2006 14 supplement 3 135S 142S
224. Meldrum B. S., Glutamate as a neurotransmitter in the brain: review of physiology and pathology The Journal of Nutrition 2000 130 supplement 4 1007S 1015S (Pubitemid 30173635)
225. Kondoh T., Torii K., Brain activation by umami substances via gustatory and visceral signaling pathways, and physiological significance Biological Pharmaceutical Bulletin 2008 31 10 1827 1832
226. Kondoh T., Mallick H. N., Torii K., Activation of the gut-brain axis by dietary glutamate and physiologic significance in energy homeostasis The American Journal of Clinical Nutrition 2009 90 3 832S 837S
227. Buckley J. D., Howe P. R., Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review Nutrients 2010 2 12 1212 1230
228. Cintra D. E., Ropelle E. R., Moraes J. C., Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity PloS ONE 2012 7 1
229. Morton G. J., Cummings D. E., Baskin D. G., Barsh G. S., Schwartz M. W., Central nervous system control of food intake and body weight Nature 2006 443 7109 289 295 (Pubitemid 44435142)
230. Lane M. D., Cha S. H., Effect of glucose and fructose on food intake via malonyl-CoA signaling in the brain Biochemical and Biophysical Research Communications 2009 382 1 1 5
231. Bello N. T., Liang N. C., The use of serotonergic drugs to treat obesityis there any hope? Drug Design, Development and Therapy 2011 5 95 109
232. Halford J. C., Harrold J. A., 5-HT(2C) receptor agonists and the control of appetite Handbook of Experimental Pharmacology 2012 209 349 356
233. Martin C., Passilly-Degrace P., Gaillard D., Merlin J. F., Chevrot M., Besnard P., The lipid-sensor candidates CD36 and GPR120 are differentially regulated by dietary lipids in mouse taste buds: impact on spontaneous fat preference PloS ONE 2011 6 8
234. Degrace-Passilly P., Besnard P., CD36 and taste of fat Current Opinion in Clinical Nutrition and Metabolic Care 2012 15 2 107 111
235. Shin Y. K., Egan J. M., Roles of hormones in taste signaling Results and Problems in Cell Differentiation 2010 52 115 137
236. Young R. L., Sensing via intestinal sweet taste pathways Frontiers in Neuroscience 2011 5, article 23
237. Niki M., Yoshida R., Takai S., Ninomiya Y., Gustatory signaling in the periphery: detection, transmission, and modulation of taste information Biological Pharmaceutical Bulletin 2010 33 11 1772 1777
238. Brolin R. E., Bariatric surgery and long-term control of morbid obesity Journal of the American Medical Association 2002 288 22 2793 2796 (Pubitemid 35425059)
239. Cummings D. E., Overduin J., Foster-Schubert K. E., Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution The Journal of Clinical Endocrinology and Metabolism 2004 89 6 2608 2615 (Pubitemid 38766339)
240. Favretti F., Ashton D., Busetto L., Segato G., De Luca M., The gastric band: first-choice procedure for obesity surgery World Journal of Surgery 2009 33 10 2039 2048
241. Li J. V., Ashrafian H., Bueter M., Kinross J., Sands C., le Roux C. W., Bloom S. R., Darzi A., Athanasiou T., Marchesi J. R., Nicholson J. K., Holmes E., Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk Gut 2011 60 9 1214 1223
242. Korner J., Inabnet W., Febres G., Conwell I. M., McMahon D. J., Salas R., Taveras C., Schrope B., Bessler M., Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass International Journal of Obesity 2009 33 7 786 795
243. le Roux C. W., Welbourn R., Werling M., Osborne A., Kokkinos A., Laurenius A., Lnroth H., Fndriks L., Ghatei M. A., Bloom S. R., Olbers T., Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass Annals of Surgery 2007 246 5 780 785 (Pubitemid 350035654)
244. Bueter M., Lwenstein C., Olbers T., Wang M., Cluny N. L., Bloom S. R., Sharkey K. A., Lutz T. A., le Roux C. W., Gastric bypass increases energy expenditure in rats Gastroenterology 2010 138 5 1845 1853
245. Laville M., Disse E., Bariatric surgery for diabetes treatment: why should we go rapidly to surgery Diabetes Metabolism 2009 35 6, part 2 562 563
246. Musso G., Gambino R., Cassader M., Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 2010 33 10 2277 2284
247. Qin J., Li R., Raes J., A human gut microbial gene catalogue established by metagenomic sequencing Nature 2010 464 7285 59 65
248. Bckhed F., Ding H., Wang T., Hooper L. V., Gou Y. K., Nagy A., Semenkovich C. F., Gordon J. I., The gut microbiota as an environmental factor that regulates fat storage Proceedings of the National Academy of Sciences of the United States of America 2004 101 44 15718 15723 (Pubitemid 39473554)
249. Bckhed F., Manchester J. K., Semenkovich C. F., Gordon J. I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice Proceedings of the National Academy of Sciences of the United States of America 2007 104 3 979 984 (Pubitemid 46154722)
250. Cani P. D., Lecourt E., Dewulf E. M., Sohet F. M., Pachikian B. D., Naslain D., De Backer F., Neyrinck A. M., Delzenne N. M., Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal American Journal of Clinical Nutrition 2009 90 5 1236 1243
251. Everard A., Lazarevic V., Derrien M., Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice Diabetes 2011 60 11 2775 2786
252. Muccioli G. G., Naslain D., Bckhed F., Reigstad C. S., Lambert D. M., Delzenne N. M., Cani P. D., The endocannabinoid system links gut microbiota to adipogenesis Molecular Systems Biology 2010 6, article 392